Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vigor and LDR in Parkinson Disease
NCT04821830Phase 4Completed
- Sponsor
- University of Michigan
- Start
- Feb 2020
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levodopa in Parkinson's disease (PD), sponsored by University of Michigan. Started Feb 2020; status: completed.
02
Drugs
levodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT04821830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04821830.